Navigation Links
Investigational agent targets gene signaling pathways to improve response for patients with CLL
Date:12/8/2012

s and increasing their risk of developing treatment-related acute myeloid leukemia.

To understand if ibrutinib may be effective for elderly CLL patients and to identify which patients might benefit most from the drug, researchers enrolled 116 CLL patient participants in several treatment cohorts: patients who were never treated (the treatment-nave group), those who had received two or more prior therapies (the relapsed/refractory group), those who had relapsed within two years of treatment (the high-risk group), and those over age 65. Two oral dosing regimens (420 mg or 840 mg daily) of ibrutinib were used. The primary goal of the study was to determine the safety of the low and high doses; secondary objectives included efficacy, measures of the intensity of the drug's effect in the body, and the long-term safety of administering this therapy continuously until relapse.

The study found that response to therapy was high across the cohorts, with largely manageable toxicities. Previously untreated elderly patients responded best to the agent, with 71 percent experiencing a complete or partial response at either treatment dose. The same response was observed in 67 percent of the relapsed patients and 50 percent of the high-risk patient cohort. After 22 months of follow-up, the disease had not progressed in 96 percent of previously untreated patients and 76 percent of relapsed and high-risk patients.

The treatment regimen was generally well-tolerated, as only non-severe side effects were observed, including diarrhea, fatigue, chest infection, rash, nausea, joint pain, and infrequent and transient low blood counts. Investigators found no evidence of cumulative toxicity or long-term safety concerns with a median follow-up of 16 months for treated patients. These results demonstrate ibrutinib's potential as a highly active, well-tolerated first-line therapy for CLL.

"As we learn more about how to target specific essential survival signa
'/>"/>

Contact: Andrea Slesinski
aslesinski@hematology.org
614-352-5096
American Society of Hematology
Source:Eurekalert

Page: 1 2 3 4 5 6

Related medicine news :

1. Updated Clinical Results Show Experimental Agent Ibrutinib as Highly Active in CLL Patients
2. Rilpivirine for HIV: Added benefit for single agent proven
3. Travel Services (MyTSOnline) in Valencia Teams Up With Vendors to Become the Number One Travel Agent in the Santa Clarita Valley
4. Mayo Clinic gets FDA approval for new imaging agent for recurrent prostate cancer
5. Scientists ID Cancer-Causing Agent in Smokeless Tobacco
6. Therapy combining exercise and neuroprotective agent shows promise for stroke victims
7. New substances 15,000 times more effective in destroying chemical warfare agents
8. Difficult to diagnose cases of infectious endocarditis solved with SPECT/CT imaging agent
9. Imaging agents predict breast cancer response to endocrine therapy
10. Pig stomach mucins are effective as anti-viral agents for consumer products
11. Method developed by VTT targets diagnosis of early Alzheimers disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/4/2015)... (PRWEB) , ... September 04, 2015 , ... Mike Day, ... in 2007, will compete in the Ironman World Championships in Kona on October 10th. ... have incurred Traumatic Brain Injury (TBI) through combat and the cutting-edge treatments that restore ...
(Date:9/4/2015)... ... 04, 2015 , ... The conference program for the upcoming ... 9-10, 2015 at the Diplomat Resort & Spa has been announced and is ... at the top of their field and will be presenting sessions such as ...
(Date:9/4/2015)... , ... September 04, 2015 , ... ... Benker Residence in South Glastonbury, Connecticut, has been selected for the Residential Award ... significant energy efficiency and resiliency measures. Chosen from a highly competitive field of ...
(Date:9/4/2015)... ... 2015 , ... EMED Jamaica Global Ltd. (EMED), Jamaica’s premier ... into a multi-year agreement with Health City Cayman Islands. , ( http://www.healthcitycaymanislands.com ) ... healthcare, Jamaican healthcare and Health City Cayman Islands to deliver high-quality, affordable healthcare ...
(Date:9/3/2015)... ... 2015 , ... Allied Anesthesia is proud to announce a continuing partnership with ... exception. , St. Jude was recently named one of the nation’s top stroke centers ... of only 10 hospitals in the state to earn the distinction. , The ...
Breaking Medicine News(10 mins):Health News:Navy SEAL Shot 27 Times Competes in Ironman World Championship in Kona to Raise Money for Veteran's Suffering from TBI and PTSD 2Health News:Integrative Healthcare Symposium Focus On: The Microbiome Conference Program Announced 2Health News:South Glastonbury Home Selected for Award by Connecticut Green Building Council 2Health News:EMED Agreement with Health City Cayman Islands Provides for Up to 80% Savings for Patients in Need of Medical Procedures 2Health News:EMED Agreement with Health City Cayman Islands Provides for Up to 80% Savings for Patients in Need of Medical Procedures 3Health News:EMED Agreement with Health City Cayman Islands Provides for Up to 80% Savings for Patients in Need of Medical Procedures 4Health News:EMED Agreement with Health City Cayman Islands Provides for Up to 80% Savings for Patients in Need of Medical Procedures 5Health News:EMED Agreement with Health City Cayman Islands Provides for Up to 80% Savings for Patients in Need of Medical Procedures 6Health News:Allied Anesthesia Physicians Announce Partnership with St. Jude 2Health News:Allied Anesthesia Physicians Announce Partnership with St. Jude 3
... or Relenza, according to CDC , TUESDAY, Sept. 8 ... which are effective in treating the H1N1 swine flu, should ... those at high risk for complications from the disease, U.S. ... with underlying health conditions, such as asthma or diabetes, as ...
... , OAKLAND, Calif., Sept. 8 (Nasdaq: ... on August 31, 2009, the Company received a NASDAQ Staff Deficiency ... Listing Rule 5550(a)(4). This rule requires the Company to maintain ... the NASDAQ Capital Market. Subsequently on September 4, 2009, the Company ...
... MOUNTAIN VIEW, Calif., Sept. 8 VIVUS, Inc. (Nasdaq: ... and commercialization of novel therapeutic products, plans to announce the results ... on September 9th prior to market open. The announcement will ... Eastern time. , , Conference Call Information ...
... AUSTIN, Texas, Sept. 8 Organix-South, a manufacturer of ... Council,s (ABC) Adopt-an-Herb program by adopting ... will provide ABC with financial support to ensure that summaries ... ( Azadirachta indica ) are made available within ABC,s HerbMedPro ...
... , Expanding facility will provide training ... the Highbridge area of the Bronx , , ... officially open the newest addition to the non-profit agency on September ... cutting ceremony at the facility. Located at 1438 Ogden Ave., ...
... , INDIANAPOLIS, Sept. 8 WellPoint, Inc. (NYSE: ... to present at the 2009 Morgan Stanley Global Healthcare Unplugged Conference ... All interested parties are invited to listen to the webcast ... selecting the "Investor Info" link. Following the presentation, a webcast replay ...
Cached Medicine News:Health News:Antiviral Drugs Should Be Used Cautiously to Fight Flu, U.S. Says 2Health News:Antiviral Drugs Should Be Used Cautiously to Fight Flu, U.S. Says 3Health News:NASDAQ Stock Market Confirms WorldHeart's Compliance with NASDAQ Listing Rule 5550(a)(4) 2Health News:VIVUS to Host Conference Call and Webcast Discussion of Qnexa Phase 3 Results 2Health News:Organix-South Adopts Neem Through the American Botanical Council's Adopt-an-Herb Program 2Health News:Organix-South Adopts Neem Through the American Botanical Council's Adopt-an-Herb Program 3Health News:Organix-South Adopts Neem Through the American Botanical Council's Adopt-an-Herb Program 4Health News:Highbridge Community Life Center Grand Opening and Ribbon Cutting Ceremony for New Health Careers/Education Facility in the Bronx 2Health News:WellPoint Announces Appearance at Upcoming Conference 2
(Date:9/4/2015)... 4, 2015  Cumberland Pharmaceuticals (CPIX), today announced that ... at VirtualInvestorConferences.com on September 10, 2015. DATE: ... LINK: http://tinyurl.com/sep10pre This will ... invited to ask the company questions in real-time - ... association,s "virtual trade booth." If attendees are not able ...
(Date:9/4/2015)... September 4, 2015 Future Prospects ... Allergic Rhinitis drugs - new study ... Where is the market for allergic rhinitis drugs heading? ... Visiongain ,s new report shows you potential revenues and ... Our 326 page report provides 273 tables, ...
(Date:9/4/2015)... Research and Markets ... the "Veterinary Pharmaceutical Submissions in the EU ... to their offering. This practical two-day ... constituent parts of the application for marketing authorisation ... marketing authorisation is sought in the European Union, ...
Breaking Medicine Technology:Cumberland Pharmaceuticals to Webcast, Live, at VirtualInvestorConferences.com September 10 2Allergic Rhinitis Drugs Market Forecast 2015-2025 2Allergic Rhinitis Drugs Market Forecast 2015-2025 3Allergic Rhinitis Drugs Market Forecast 2015-2025 4Allergic Rhinitis Drugs Market Forecast 2015-2025 5Allergic Rhinitis Drugs Market Forecast 2015-2025 6Allergic Rhinitis Drugs Market Forecast 2015-2025 7Veterinary Pharmaceutical Submissions in the EU: Two day Course - London, UK - December 7-8, 2015 2
... MADISON, N.J., Aug. 12, 2011 Quest Diagnostics ... of diagnostic testing, information and services, today announced that its ... per share, payable on October 24, 2011, to shareholders of record ... About Quest Diagnostics Quest Diagnostics ...
... HeartWare International, Inc. (NASDAQ: HTWR ; ASX: ... support technologies that are revolutionizing the treatment of advanced ... scheduled to make an investor presentation at the Wedbush ... a.m. Eastern Time on Wednesday, August 17, 2011.  The ...
Cached Medicine Technology:HeartWare to Present at the Wedbush Securities 2011 Life Sciences Management Access Conference 2
CCR Medical fiberoptic green system laryngoscope handles., ,OUTSTANDING PERFORMANCE, QUALITY, AND PRICING MAKE OUR FIBEROPTIC SELECTION MOST ECONOMICAL....
CCR Medical conventional laryngoscopes....
CCR Medical conventional laryngoscopes....
... LMA™ Airway., ,Launched in 1988, this ... is now standard practice in general anesthesia. ... the LMA Classic™ is a safe hands ... ,The LMA Classic™ can be used for ...
Medicine Products: